CYCC Oversold Previously, Now Everyone's Buying

ロング

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC)

NASDAQ:CYCC Cyclacel Pharmaceuticals, Inc.

bullish oversold cyclacel pharmaceuticals funds insiders buying float

It gapped down in the past because they dropped one of their studies but the company has many other products in development. There are messages that the float has been bought up and funds and insiders are buying heavily for some event.

免責事項

これらの情報および投稿は、TradingViewが提供または保証する金融、投資、取引、またはその他の種類のアドバイスや推奨を意図したものではなく、またそのようなものでもありません。詳しくは利用規約をご覧ください。